Brent is a member of the commercial team at RIS Rx, focused on making copay assistance more sustainable through gross-to-net (GTN) revenue protection and improved patient experience. His work and thought leadership frequently connects patient affordability pain points to actionable mitigation strategies for manufacturer copay programs. Brent spent 30 years in pharma mostly in market access roles prior to joining RIS Rx and has an MBA from The Thunderbird School of Global Management.